Entresto: Side effects, dosage, cost, uses, alternatives, and more

If you’ve ever read a prescription label and thought, “Ah yes, this medicine clearly has two last names,”
you’re not alone. Entresto is one of those combo medications (generic name:
sacubitril/valsartan) that shows up in heart failure treatment plansoften with the energy of a
helpful coworker who says, “I can do both jobs.”

This guide covers what Entresto is used for, how dosing typically works, what side effects to watch for, what it may
cost, and what alternatives exist. It’s written for everyday humans, not just cardiology textbooks. Still: heart
failure is serious, and medication decisions should always be made with a clinician who knows your history, labs, and
blood pressure trends.

What is Entresto?

Entresto is a prescription medication that combines two drugs:
sacubitril and valsartan. It belongs to a class called
ARNIs (angiotensin receptor–neprilysin inhibitors). In plain English: it’s designed to support the
heart and circulation by helping the body hold onto “helpful” signaling chemicals while also blocking a pathway that
can worsen fluid retention and blood vessel tightening.

What does it treat?

In the U.S., Entresto is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure
in adults with chronic heart failure, with benefits most clearly evident when the left ventricular ejection fraction
(LVEF) is below normal. It’s also indicated in certain pediatric patients (age 1 and older) with symptomatic heart
failure and systemic left ventricular systolic dysfunction. (Yes, kids’ dosing is its own universemore on that
below.)

How Entresto works (without the chemistry headache)

Entresto works in two complementary ways:

• Sacubitril inhibits neprilysin, an enzyme that breaks down natriuretic peptides. Those peptides
  help the body get rid of extra sodium and fluid, relax blood vessels, and reduce strain on the heart.
• Valsartan is an ARB (angiotensin II receptor blocker). It blocks signals that can tighten blood
  vessels and promote salt and water retentiontwo things heart failure really doesn’t need more of.

The combo can help reduce the workload on the heart over time. You’ll rarely “feel” the benefit overnight (this is
not a caffeine situation), but many patients take it as part of a long-term plan to improve outcomes and reduce
hospitalizations.

Entresto uses: who it’s for (and who it’s not)

Common adult use

Entresto is commonly prescribed for adults with chronic heart failure, especially
HFrEF (heart failure with reduced ejection fraction) or when LVEF is below normal. Many heart
failure guidelines include an ARNI like sacubitril/valsartan among key disease-modifying therapies for chronic,
symptomatic HFrEF.

Pediatric use

For pediatric patients aged 1 year and older with symptomatic heart failure and systemic left
ventricular systolic dysfunction, Entresto can be used with weight-based dosing and titration schedules.

When Entresto is not appropriate

Entresto is not for everyone. It should not be used with an ACE inhibitor at the same time, and it
should not be started too soon after stopping an ACE inhibitor (there’s a required waiting period). It’s also
contraindicated in patients with a history of angioedema related to ACE inhibitors/ARBs, and it has a boxed warning
for fetal toxicitymeaning it can cause harm during pregnancy.

Entresto dosage: strengths, typical schedules, and how titration works

Available strengths

Entresto tablets commonly come in these strengths:

• 24/26 mg (sacubitril/valsartan)
• 49/51 mg
• 97/103 mg

Typical adult dosing approach

Adult dosing is usually twice daily. A commonly cited starting dose is
49/51 mg twice daily, with dose doubling after a few weeks to a target maintenance dose of
97/103 mg twice daily, as tolerated. Some people start lower (such as 24/26 mg twice daily) based on
prior therapy, kidney function, or blood pressure.

The “ACE inhibitor switch” rule: the 36-hour washout

If switching from an ACE inhibitor (like lisinopril or enalapril) to Entresto, there’s a required
36-hour washout period between the two. This is to reduce the risk of angioedema. Put differently:
your heart meds don’t like overlapping shifts when an ACE inhibitor is involved.

How to take it

• Usually taken twice daily.
• Can be taken with or without food (unless your clinician tells you otherwise).
• Try to take it at consistent timesthink “breakfast and dinner,” not “whenever I remember after midnight.”
• If you miss a dose, take the next dose at the scheduled timedon’t double up unless your clinician specifically
  instructs you to.

Forms for patients who can’t swallow tablets (pediatric and some adults)

For patients who can’t swallow tablets, Entresto may be prepared as an oral suspension (pharmacy-compounded from
tablets) or given as oral pellets that are sprinkled on soft food. The pellet form should not be chewed or crushed,
and it isn’t meant to be administered through feeding tubes due to obstruction risk.

Monitoring while titrating

Clinicians often monitor:

• Blood pressure (especially in the first weeks or after dose increases)
• Kidney function (serum creatinine/eGFR)
• Potassium (hyperkalemia risk increases in some patients)
• Symptoms like dizziness, fatigue, swelling, or shortness of breath

Entresto side effects

Side effects range from “annoying but manageable” to “call emergency services now.” The key is knowing what’s common,
what’s serious, and what’s a “let’s message the cardiology team today” situation.

Common side effects

• Low blood pressure (hypotension): may cause dizziness or lightheadedness, especially when standing
  up quickly.
• Dizziness or feeling faint
• Cough (less iconic than ACE-inhibitor cough, but it can happen)
• High potassium (hyperkalemia)
• Changes in kidney function

Serious side effects (get help immediately)

• Angioedema (swelling of face, lips, tongue, or throat; trouble breathing or swallowing). This is a
  medical emergency.
• Severe hypotension (fainting, confusion, inability to stand, severe weakness)
• Severe hyperkalemia (can cause abnormal heart rhythms; symptoms may include weakness or a pounding
  or irregular heartbeat)
• Severe kidney injury (significant drop in urination, swelling, sudden weight gain, extreme fatigue)
• Pregnancy-related harm: Entresto can cause fetal harm; it should be stopped as soon as pregnancy is
  detected.

Practical tips for managing “common” side effects

• For dizziness: stand up slowly, especially in the first few days. Hydration matters, but in heart
  failure it must be balancedfollow your clinician’s fluid guidance.
• For low blood pressure: track home BP if asked. A pattern of very low readings or symptoms should
  be reported.
• For potassium: avoid adding potassium supplements or salt substitutes unless prescribed. Labs are
  your friend here.
• For kidney function: avoid “just because” NSAID use (like ibuprofen) without discussing itNSAIDs
  can worsen renal function when combined with certain heart meds.

Drug interactions and precautions

Medications that generally should not be combined with Entresto

• ACE inhibitors: contraindicated with Entresto; requires a 36-hour washout when switching.
• Another ARB: generally avoided because Entresto already contains valsartan.
• Aliskiren: contraindicated in patients with diabetes, and generally avoided in certain renal
  impairment contexts.

Medications that require extra caution

• Potassium-sparing diuretics (like spironolactone), potassium supplements, and potassium-based salt
  substitutes: may increase potassium levels further.
• NSAIDs (including COX-2 inhibitors): in certain patients (elderly, volume-depleted, kidney
  disease), combining NSAIDs with Entresto can worsen kidney function; periodic monitoring may be advised.
• Lithium: ARB-related effects can increase lithium levels and toxicity risk; monitoring may be
  needed.

Other key warnings

• Pregnancy: not recommended; discontinue as soon as pregnancy is detected.
• Angioedema history: if you’ve had angioedema with ACE inhibitors/ARBs, Entresto may not be safe.
• Kidney disease: dose selection and monitoring may differ; clinicians may start lower and monitor
  creatinine/potassium closely.
• Low blood pressure: may need lower starting dose or medication adjustments.

Entresto cost: what to expect and how people lower the price

Let’s be honest: “cost” is often the side effect nobody warned you about.
The out-of-pocket price for brand-name Entresto can be high if you’re paying cash, though actual patient costs vary
widely based on insurance, pharmacy, and assistance programs.

Brand vs generic

Generic versions of sacubitril/valsartan were FDA-approved earlier and later launched commercially in the U.S. in
July 2025. That’s important because generics can reduce costs, but prices still vary by plan,
pharmacy, and supply chain realities.

Ways patients commonly reduce cost

• Insurance formularies: some plans cover Entresto well; others require prior authorization or step
  therapy.
• Manufacturer copay offers: eligible commercially insured patients may qualify for low copays (often
  advertised as low as a set amount for a multi-month supply).
• Discount cards and pharmacy coupons: these can help cash-paying patients, particularly if a generic
  is available.
• Patient assistance programs: for people who meet income/coverage criteria.

A practical approach: ask your clinician to write the prescription in a way that allows substitution when appropriate
(brand vs generic), and ask the pharmacy to run both options. It’s not glamorous, but neither is heart failure, and
we all do what we must.

Entresto alternatives (and when they’re used)

Alternatives depend on why Entresto is being considered in the first place. Sometimes the alternative is a different
drug. Sometimes it’s the same goal (heart failure risk reduction) achieved through a different combination of
therapies.

Medication alternatives in the same “pathway”

• ACE inhibitors (e.g., enalapril, lisinopril) commonly used in HFrEF if ARNI isn’t feasible.
• ARBs (e.g., valsartan, losartan, candesartan) used when ACE inhibitors aren’t tolerated.

Other key heart failure medications that may be used alongside (not necessarily instead)

• Evidence-based beta blockers (e.g., carvedilol, metoprolol succinate, bisoprolol)
• Mineralocorticoid receptor antagonists (MRAs) (e.g., spironolactone, eplerenone)
• SGLT2 inhibitors (e.g., dapagliflozin, empagliflozin)
• Diuretics (e.g., furosemide) for symptom relief from congestion (they help you pee off extra fluid)
• Hydralazine/isosorbide dinitrate in select patients (often when RAAS-blocking drugs aren’t suitable)
• Ivabradine or vericiguat in select scenarios

Translation: Entresto is often one part of a broader plan. If it’s not right for youdue to side effects, cost, or
contraindicationsthere are other evidence-based routes your clinician can take.

Frequently asked questions

How long does it take Entresto to work?

Some people notice blood pressure changes within days. Outcome benefits (like lower hospitalization risk) are about
consistent long-term use as part of a full heart failure regimen. Your clinician may look at symptoms, blood pressure,
labs, and sometimes biomarkers over time.

Can Entresto cause weight gain?

Entresto itself isn’t typically described as a “weight gain medicine.” In heart failure, rapid weight gain often
signals fluid retention. If your weight jumps suddenly over a short period, contact your cliniciandon’t assume it’s
holiday cookies acting alone.

Is Entresto safe with kidney disease?

It may be used in some patients with kidney disease, often with dose adjustments and closer monitoring of kidney
function and potassium. Your clinician will weigh benefits and risks based on your labs and symptoms.

What should I avoid while taking Entresto?

Avoid combining it with ACE inhibitors and avoid starting it too soon after stopping an ACE inhibitor. Also be
cautious with potassium supplements/salt substitutes, and check with a clinician before using NSAIDs regularly.

Extra: Real-world experiences with Entresto (patient and clinician perspectives)

The internet is full of Entresto stories that range from “life-changing” to “why am I dizzy when I stand up?” Both
can be truebecause the first weeks often look different from the three-month mark.

1) The “first week wobble” (blood pressure and dizziness)

Many patients describe a short adjustment period when starting Entresto or after a dose increaseespecially if they
already take diuretics or have a naturally lower baseline blood pressure. A common theme is feeling lightheaded when
standing up fast (the classic “I stood up and briefly met my ancestors” moment). Clinicians often respond by checking
home blood pressure logs, reviewing other blood pressure–lowering medications, and deciding whether the Entresto dose
should be started lower or titrated more slowly.

Practical experience tip: patients who do best often treat the first week like a “monitoring phase.” They track BP if
asked, stand up slowly, and report persistent dizziness rather than toughing it out. That’s not complainingit’s good
data.

2) Lab checks feel boring… until they save you trouble

People don’t usually post, “Today I had a perfectly normal potassium level!” (which is honestly a shamewe should
celebrate more). But in real life, clinicians frequently order potassium and kidney function labs after starting or
titrating Entresto. Why? Because mild kidney function changes or rising potassium can happen silently. Catching a
trend early may allow a simple fix: adjusting a diuretic, reviewing salt substitutes, rethinking a potassium
supplement, or spacing out titration.

A very common scenario: someone starts Entresto and also takes spironolactone. Both can influence potassium, so
clinicians often monitor more closely and coach patients to avoid potassium-based salt substitutes (the “healthy”
swap that sometimes backfires in heart failure).

3) The insurance obstacle course

Real-world use includes something no clinical trial can fully capture: prior authorizations, step therapy, and
pharmacy surprises. Patients often report that the first fill is the hardest. After that, refills can become routine
(or at least routine-adjacent).

What helps in practice:

• Asking the pharmacy to run both brand and generic pricing (when substitution is appropriate).
• Checking whether a 90-day supply reduces copays.
• Using manufacturer copay offers if eligible and commercially insured.
• Having the prescriber’s office send documentation quickly if prior authorization is required.

4) The “I feel better, can I stop?” temptation

Clinicians regularly see a pattern: a patient’s symptoms stabilize, they breathe easier, and they wonder if they still
need the meds. Heart failure treatment is often about maintaining gains, not just achieving them. Many patients do
best when they view Entresto as part of a long-term foundationlike brushing teeth, but for your cardiovascular
system (and with fewer mint flavors).

5) The best Entresto experience is usually… the one with teamwork

The most positive stories tend to involve a clinician who explains the “why,” a patient who reports symptoms early,
and follow-up visits that adjust the plan based on BP readings, labs, and daily function. When Entresto isn’t a good
fitbecause of hypotension, hyperkalemia, angioedema risk, pregnancy, or costpeople often still do well with
alternatives and guideline-based combinations. The goal isn’t to “win Entresto.” The goal is to keep you out of the
hospital and living more of your life.

Bottom line

Entresto (sacubitril/valsartan) is a key heart failure medication for many adults with chronic heart failureespecially
when LVEF is below normaland it has pediatric indications in specific cases. Like any powerful medication, it can
cause side effects (most commonly low blood pressure, dizziness, cough, high potassium, and kidney function changes),
and it has important warnings (including angioedema risk and fetal toxicity). Dosing is typically twice daily with
titration toward a target dose as tolerated.

If you’re considering Entrestoor already taking ityour best tools are simple: consistent dosing, honest symptom
tracking, periodic lab monitoring, and a quick check-in when something feels off. That, and not letting your heart
meds overlap in ways they specifically told you not to.